End-of-day quote
Other stock markets
|
||
- GBX | - |
14/05 | RELX : UBS remains its Buy rating | ZD |
14/05 | UBS Raises Relx PT, Keeps Buy Rating | MT |
Sales 2024 * | 975.42Cr 1.24TCr 1,03100Cr | Sales 2025 * | 1.03TCr 1.31TCr 1,09200Cr | Capitalization | 6.46TCr 8.2TCr 6,82900Cr |
---|---|---|---|---|---|
Net income 2024 * | 203.8Cr 258.83Cr 22TCr | Net income 2025 * | 222.9Cr 283.08Cr 24TCr | EV / Sales 2024 * | 7.27 x |
Net Debt 2024 * | 630.75Cr 801.05Cr 67TCr | Net Debt 2025 * | 617.05Cr 783.65Cr 65TCr | EV / Sales 2025 * | 6.85 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
29.1
x | Employees | - |
Yield 2024 * |
1.82% | Yield 2025 * |
1.97% | Free-Float | 98.25% |
Latest transcript on Reed Elsevier plc
Managers | Title | Age | Since |
---|---|---|---|
Erik Engstrom
CEO | Chief Executive Officer | 60 | 01/04/01 |
Nick Luff
DFI | Director of Finance/CFO | 57 | 24/14/24 |
Vijay Raghavan
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charlotte Hogg
BRD | Director/Board Member | 53 | 16/19/16 |
Andrew Sukawaty
BRD | Director/Board Member | 69 | 25/19/25 |
Nick Luff
DFI | Director of Finance/CFO | 57 | 24/14/24 |
1st Jan change | Capi. | |
---|---|---|
-13.48% | 19TCr | |
+1.07% | 17TCr | |
+3.37% | 16TCr | |
+8.31% | 10TCr | |
+35.49% | 8.2TCr | |
-6.39% | 7.21TCr | |
-18.66% | 5.51TCr | |
-9.06% | 4.37TCr | |
+9.88% | 3.85TCr |